rs142056835

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_006612.6(KIF1C):​c.1111G>A​(p.Ala371Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00426 in 1,614,248 control chromosomes in the GnomAD database, including 20 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0036 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0043 ( 19 hom. )

Consequence

KIF1C
NM_006612.6 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.13
Variant links:
Genes affected
KIF1C (HGNC:6317): (kinesin family member 1C) The protein encoded by this gene is a member of the kinesin-like protein family. The family members are microtubule-dependent molecular motors that transport organelles within cells and move chromosomes during cell division. Mutations in this gene are a cause of spastic ataxia 2, autosomal recessive. [provided by RefSeq, May 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01151219).
BP6
Variant 17-5004946-G-A is Benign according to our data. Variant chr17-5004946-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 424675.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, Likely_benign=4}.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00355 (541/152368) while in subpopulation NFE AF = 0.00525 (357/68040). AF 95% confidence interval is 0.0048. There are 1 homozygotes in GnomAd4. There are 268 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High Homozygotes in GnomAdExome4 at 19 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KIF1CNM_006612.6 linkc.1111G>A p.Ala371Thr missense_variant Exon 13 of 23 ENST00000320785.10 NP_006603.2 O43896
KIF1CXM_005256424.3 linkc.1111G>A p.Ala371Thr missense_variant Exon 14 of 24 XP_005256481.1 O43896

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KIF1CENST00000320785.10 linkc.1111G>A p.Ala371Thr missense_variant Exon 13 of 23 1 NM_006612.6 ENSP00000320821.5 O43896

Frequencies

GnomAD3 genomes
AF:
0.00355
AC:
541
AN:
152250
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000506
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.00720
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000827
Gnomad FIN
AF:
0.00593
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00525
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00337
AC:
847
AN:
251406
AF XY:
0.00327
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00254
Gnomad ASJ exome
AF:
0.00387
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00661
Gnomad NFE exome
AF:
0.00464
Gnomad OTH exome
AF:
0.00489
GnomAD4 exome
AF:
0.00434
AC:
6342
AN:
1461880
Hom.:
19
Cov.:
32
AF XY:
0.00428
AC XY:
3109
AN XY:
727238
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
AC:
8
AN:
33480
Gnomad4 AMR exome
AF:
0.00253
AC:
113
AN:
44724
Gnomad4 ASJ exome
AF:
0.00383
AC:
100
AN:
26136
Gnomad4 EAS exome
AF:
0.0000252
AC:
1
AN:
39700
Gnomad4 SAS exome
AF:
0.000325
AC:
28
AN:
86258
Gnomad4 FIN exome
AF:
0.00687
AC:
367
AN:
53410
Gnomad4 NFE exome
AF:
0.00497
AC:
5528
AN:
1112008
Gnomad4 Remaining exome
AF:
0.00323
AC:
195
AN:
60396
Heterozygous variant carriers
0
391
782
1174
1565
1956
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00355
AC:
541
AN:
152368
Hom.:
1
Cov.:
32
AF XY:
0.00360
AC XY:
268
AN XY:
74516
show subpopulations
Gnomad4 AFR
AF:
0.000505
AC:
0.000504929
AN:
0.000504929
Gnomad4 AMR
AF:
0.00431
AC:
0.0043126
AN:
0.0043126
Gnomad4 ASJ
AF:
0.00720
AC:
0.00720046
AN:
0.00720046
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000827
AC:
0.000827472
AN:
0.000827472
Gnomad4 FIN
AF:
0.00593
AC:
0.00592662
AN:
0.00592662
Gnomad4 NFE
AF:
0.00525
AC:
0.00524691
AN:
0.00524691
Gnomad4 OTH
AF:
0.00189
AC:
0.00189036
AN:
0.00189036
Heterozygous variant carriers
0
24
47
71
94
118
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00415
Hom.:
5
Bravo
AF:
0.00308
TwinsUK
AF:
0.00378
AC:
14
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00430
AC:
37
ExAC
AF:
0.00351
AC:
426
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00409
EpiControl
AF:
0.00344

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia Uncertain:1Benign:1
Mar 29, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 07, 2017
Unit for Genetic & Epidemiological Research on Neurological Disorders, Instituto de Investigação e Inovação em Saúde
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Benign:1
Oct 27, 2017
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Spastic ataxia 2 Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KIF1C: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.39
T
BayesDel_noAF
Benign
-0.32
CADD
Benign
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.10
T
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.32
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.91
D
M_CAP
Benign
0.017
T
MetaRNN
Benign
0.012
T
MetaSVM
Benign
-0.63
T
MutationAssessor
Benign
1.6
L
PrimateAI
Uncertain
0.50
T
PROVEAN
Benign
0.70
N
REVEL
Benign
0.15
Sift
Benign
0.81
T
Sift4G
Benign
0.65
T
Polyphen
0.92
P
Vest4
0.17
MVP
0.73
MPC
0.44
ClinPred
0.030
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.10
gMVP
0.46
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142056835; hg19: chr17-4908241; COSMIC: COSV99077308; COSMIC: COSV99077308; API